Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Nov 11:11:859.
doi: 10.1186/1471-2458-11-859.

Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study

Francisco Martin-Lujan  1 , Josep L I Piñol-Moreso, Nuria Martin-Vergara, Josep Basora-Gallisa, Irene Pascual-Palacios, Ramon Sagarra-Alamo, Estefania Aparicio Llopis, Maria T Basora-Gallisa, Roser Pedret-Llaberia; ESPITAP Study Group investigators
Collaborators, Affiliations
Randomized Controlled Trial

Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study

Francisco Martin-Lujan et al. BMC Public Health. .

Abstract

Background: There is current controversy about the efficacy of smoking cessation interventions that are based on information obtained by spirometry. The objective of this study is to evaluate the effectiveness in the primary care setting of structured motivational intervention to achieve smoking cessation, compared with usual clinical practice.

Design: Multicentre randomized clinical trial with an intervention and a control group.

Setting: 12 primary care centres in the province of Tarragona (Spain).

Subjects of study: 600 current smokers aged between 35 and 70 years with a cumulative habit of more than 10 packs of cigarettes per year, attended in primary care for any reason and who did not meet any of the exclusion criteria for the study, randomly assigned to structured intervention or standard clinical attention.

Intervention: Usual advice to quit smoking by a general practitioner as well as a 20-minute personalized visit to provide detailed information about spirometry results, during which FEV1, FVC, FEF 25-75% and PEF measurements were discussed and interpreted in terms of theoretical values. Additional information included the lung age index (defined as the average age of a non-smoker with the same FEV1 as the study participant), comparing this with the chronological age to illustrate the pulmonary deterioration that results from smoking.

Measurements: Spirometry during the initial visit. Structured interview questionnaire administered at the primary care centre at the initial visit and at 12-month follow-up. Telephone follow-up interview at 6 months. At 12-month follow-up, expired CO was measured in patients who claimed to have quit smoking.

Main variables: Smoking cessation at 12 months.

Analysis: Data will be analyzed on the basis of "intention to treat" and the unit of analysis will be the individual smoker.

Expected results: Among active smokers treated in primary care we anticipate significantly higher smoking cessation in the intervention group than in the control group.

Discussion: Application of a motivational intervention based on structured information about spirometry results, improved abstinence rates among smokers seen in actual clinical practice conditions in primary care.

Trial registration: ClinicalTrial.gov, number NCT01194596.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of the ESPITAP study: process of selection, randomization and follow-up of subjects included in the study.
See this image and copyright information in PMC

References

    1. Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO Workshop Report. Reviewed. 2010. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease.http://www.goldcopd.org/ - PubMed
    1. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180:3–10. doi: 10.1164/rccm.200901-0047OC. - DOI - PubMed
    1. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61:935–939. doi: 10.1136/thx.2006.062802. - DOI - PMC - PubMed
    1. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18:213–221. doi: 10.1183/09059180.00003609. - DOI - PubMed
    1. Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276. - PubMed

Publication types

Associated data